Page results
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
Professor Karl Peggs was appointed to the Board in August 2024 as the director of research and director of the National Institute for Health and Care Research (NIHR) UCLH Biomedical Research Centre (BRC).
-
As photographer Tom Pilston searched for a way to make his contribution during the Covid-19 pandemic, he cast around for a project which would allow him to pay tribute to the NHS he describes as "all that is good about the UK ... humane and caring, hard-working, sensitive and strong".
-
More than 400 patients at UCLH have so far benefited from an exciting new cancer treatment called proton beam therapy (PBT) – which uses high-energy beams of protons, rather than X-rays, to deliver a dose of radiotherapy.
-
Charity Myeloma UK awards UCLH haematology team their Clinical Service Excellence Programme (CSEP) award in recognition of their outstanding care and unflagging dedication to patients living myeloma, an incurable blood cancer.
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
This page answers common questions asked by colorectal patients.
-
UCLH Learning Disabilities and Autism Team Telephone: 020 3447 8238 Email: uclh.referrals.learning.disabilities@nhs.net…
-
UCLH patient information for using Control IQ technology.
File results
-
FOI/2024/0628 - Service personnel/ armed force families access to speech and language therapy for children who stammer
-
FOI/2024/0633 - Adults, children diagnosed/ living with Glycogen storage disease type V (Mcardle's disease)
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0648 - Performance management Policy for July 2020 to November 2022
-
FOI/2024/0651 - Family history units/ familial cancer services
-
FOI/2024/0652 - Overseas visitors invoiced in 2023/24
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0663 - Diagnosis discharge codes and cases 2018-19 to 2022-23
-
FOI/2024/0667 - Agency/ bank staff, master/neutral vendor/ contract and contact details 2023/24
-
FOI/2024/0668 - Doctors shifts covered by Physician Associates 01/04/2024-01/09/2024